4//SEC Filing
O'NEIL PATRICK R. 4
Accession 0000874015-25-000244
CIK 0000874015other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:35 PM ET
Size
13.5 KB
Accession
0000874015-25-000244
Insider Transaction Report
Form 4
O'NEIL PATRICK R.
EVP CLO & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-10-02$56.78/sh+30,203$1,714,926→ 87,333 total - Exercise/Conversion
Common Stock
2025-10-02$60.89/sh+34,461$2,098,330→ 91,591 total - Sale
Common Stock
2025-10-02$67.69/sh−34,461$2,332,638→ 57,130 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-02−30,203→ 0 totalExercise: $56.78From: 2022-01-04Exp: 2028-01-03→ Common Stock (30,203 underlying) - Sale
Common Stock
2025-10-02$67.69/sh−30,203$2,044,417→ 57,130 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-02−34,461→ 0 totalExercise: $60.89From: 2020-01-01Exp: 2027-01-01→ Common Stock (34,461 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.03 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001564926
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:35 PM ET
- Size
- 13.5 KB